Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a
technology-enabled platform providing exit opportunities and
primary capital solutions and related trust and custody services to
holders of alternative assets through its proprietary online
platform AltAccess, today announced it has closed on the financing
of a $1.36 million primary capital commitment for 8F Fund, LP
(“Fund”), a fund managed by 8F Asset Management, a global asset
manager that manages private equity funds that invest in vertically
integrated aquaculture production and processing facilities. The
transaction represents Ben’s first GP Primary transaction since its
recently announced Public Stockholder Enhancement Transactions. In
exchange for an interest in the Fund, the Fund received
approximately $1.36 million in stated value of shares of the
Company’s Resettable Convertible Preferred Stock (the “Preferred
Stock”), which is convertible at the election of the holder into
shares of the Company’s Class A common stock, subject to the terms
and conditions of the transaction documents. As a result of the
transaction, the collateral for Company’s ExAlt loan portfolio is
expected to increase by approximately $1.36 million of interests in
alternative assets.
“Closing this transaction underscores our commitment to
executing on our core liquidity and primary capital business plan
by delivering innovative capital solutions for holders and managers
of alternative assets,” said, Beneficient management. “We believe
this financing reflects our ability to drive shareholder value
while supporting impactful, vertically integrated investment
strategies that enhance the value of the collateral backing our
ExAlt loan portfolio. We look forward to building on this momentum
in 2025 as we continue to evaluate additional opportunities that
align with our strategic objectives.”
Upon closing of the previously announced Public Stockholder
Enhancement Transactions, the Company believes this transaction
will result in the addition of approximately $450K (and an
aggregate of approximately $10.23 million) of tangible book value
attributable to the Company’s stockholders.
Beneficient’s GP Primary Commitment Program is focused on
providing primary capital solutions and financing anchor
commitments to general partners during their fundraising efforts
while immediately deploying capital into our equity. Through the
program, Beneficient seeks to help satisfy the up to $330 billion
of potential demand for primary commitments to meet fundraising
needs.
Reconciliation of Non-GAAP Financial
Measures |
|
|
|
The following
tables reconciles these non-GAAP financial measures to the most
comparable GAAP financial measures as of September 30, 2024 on an
actual basis and pro forma assuming the Transactions occurred on
September 30, 2024. |
|
(dollars in thousands) |
|
Actual |
|
Pro forma – Transactions (1) |
|
Pro forma -Transactions and GP Primary
(3) |
Tangible Book
Value |
|
|
|
|
|
|
Total equity (deficit) |
|
|
(13,192 |
) |
|
(13,192 |
) |
|
(11,831 |
) |
Less: Goodwill and intangible
assets |
|
|
(13,014 |
) |
|
(13,014 |
) |
|
(13,014 |
) |
Plus: Total temporary
equity |
|
|
125,526 |
|
|
125,526 |
|
|
125,526 |
|
Tangible book value |
|
|
99,320 |
|
|
99,320 |
|
|
100,681 |
|
|
|
|
|
|
|
|
|
|
Actual |
|
Pro forma – Transactions(1) |
|
Pro forma -Transactions and GP
Primary(3) |
Tangible book value
attributable to Ben public company stockholders |
|
|
|
|
|
|
Tangible book value |
|
|
99,320 |
|
|
99,320 |
|
|
100,681 |
|
Less: Tangible book value
attributable to Beneficient Holdings noncontrolling interest
holders |
|
|
(99,320 |
) |
|
(89,388 |
) |
|
(90,454 |
) |
Tangible book value
attributable to Ben’s public company stockholders |
|
|
- |
|
|
9,932 |
(2) |
|
10,227 |
(4) |
|
|
|
|
|
|
|
Market Capitalization of Ben’s
Class A and Class B common stock as of January 3, 2024 (5) |
|
$ |
6,048 |
|
|
|
|
|
(1) |
Assumes the Transactions closed on September 30, 2024 including
that the Beneficient Holdings limited partnership agreement was
amended to provide that Ben, as the indirect holder of the Class A
Units and certain Designated Class S Ordinary Units of Beneficient
Holdings, would receive in the event of a liquidation of
Beneficient Holdings 10% of the first $100 million of distributions
of Beneficient Holdings following the satisfaction of the debts and
liabilities of Beneficient Holdings on a consolidated basis. |
(2) |
Pro forma for the Transactions,
represents 10% of the first $100 million of distributions of
Beneficient Holdings in the event of the liquidation of Beneficient
Holdings following the satisfaction of the debts and liabilities
Beneficient Holdings on a consolidated basis. |
(3) |
Assumes the Transactions closed
on September 30, 2024 including that the Beneficient Holdings
limited partnership agreement was amended to provide that Ben, as
the indirect holder of the Class A Units and certain Designated
Class S Ordinary Units of Beneficient Holdings, would receive in
the event of a liquidation of Beneficient Holdings (i) 10% of the
first $100 million of distributions of Beneficient Holdings
following the satisfaction of the debts and liabilities of
Beneficient Holdings on a consolidated basis and (ii) 33.3333% of
the net asset value of the added alternative assets of up to $5
billion in connection with ExAlt Plan liquidity and primary capital
transactions entered after December 22, 2024. |
(4) |
Pro forma for the Transactions,
represents (i) 10% of the first $100 million of distributions of
Beneficient Holdings in the event of the liquidation of Beneficient
Holdings following the satisfaction of the debts and liabilities
Beneficient Holdings on a consolidated basis and (ii) 33.3333% of
the net asset value of the added alternative assets of up to $5
billion in connection with ExAlt Plan liquidity and primary capital
transactions entered after December 22, 2024. |
(5) |
Based upon the closing price of
the Class A common stock as reported by Nasdaq as of market close
on January 3, 2025. |
|
|
About Beneficient Beneficient (Nasdaq:
BENF) – Ben, for short – is on a mission to democratize the global
alternative asset investment market by providing traditionally
underserved investors − mid-to-high net worth individuals,
small-to-midsized institutions and General Partners seeking exit
options, anchor commitments and valued-added services for their
funds− with solutions that could help them unlock the value in
their alternative assets. Ben’s AltQuote® tool provides customers
with a range of potential exit options within minutes, while
customers can log on to the AltAccess® portal to explore
opportunities and receive proposals in a secure online
environment.
Its subsidiary, Beneficient Fiduciary Financial, L.L.C.,
received its charter under the State of Kansas’ Technology-Enabled
Fiduciary Financial Institution (TEFFI) Act and is subject to
regulatory oversight by the Office of the State Bank
Commissioner.
For more information, visit www.trustben.com or follow
us on LinkedIn.
ContactsMatt Kreps: 214-597-8200,
mkreps@darrowir.comMichael Wetherington: 214-284-1199,
mwetherington@darrowir.comInvestor Relations:
investors@beneficient.com
Important Information and Where You Can Find
It
This press release may be deemed to be solicitation material in
respect of a vote of stockholders to approve an amendment to
approve the issuance of the Company’s Class A common stock upon
conversion of the Series B-5 Preferred Stock pursuant to the
transaction. In connection with the requisite stockholder approval,
Ben will file with the Securities and Exchange Commission (the
“SEC”) a preliminary proxy statement and a definitive proxy
statement, which will be sent to the stockholders of Ben, seeking
such approvals related to the transaction.
INVESTORS AND SECURITY HOLDERS OF BEN AND THEIR RESPECTIVE
AFFILIATES ARE URGED TO READ, WHEN AVAILABLE, THE PROXY STATEMENT
AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC
IN CONNECTION WITH THE TRANSACTION, AS WELL AS ANY AMENDMENTS OR
SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT
INFORMATION ABOUT BEN AND THE TRANSACTION. Investors and security
holders will be able to obtain a free copy of the proxy statement,
as well as other relevant documents filed with the SEC containing
information about Ben, without charge, at the SEC’s website
(http://www.sec.gov). Copies of documents filed with the SEC by Ben
can also be obtained, without charge, by directing a request to
Investor Relations, Beneficient, 325 North St. Paul Street, Suite
4850, Dallas, Texas 75201, or email investors@beneficient.com.
Participants in the Solicitation of Proxies in
Connection with Transaction
Ben and certain of its directors, executive officers and
employees may be deemed to be participants in the solicitation of
proxies in respect of the requisite stockholder approvals under the
rules of the SEC. Information regarding Ben’s directors and
executive officers is available in its annual report on Form 10-K
for the fiscal year ended March 31, 2024, which was filed with the
SEC on July 9, 2024 and certain current reports on Form 8-K filed
by Ben. Other information regarding the participants in the
solicitation of proxies with respect to the proposed transaction
and a description of their direct and indirect interests, by
security holdings or otherwise, will be contained in the proxy
statement and other relevant materials to be filed with the SEC.
Free copies of these documents, when available, may be obtained as
described in the preceding paragraph.
Not an Offer of Securities
The information in this communication is for informational
purposes only and shall not constitute, or form a part of, an offer
to sell or the solicitation of an offer to sell or the solicitation
of an offer to buy any securities. The securities that are the
subject of the transaction have not been registered under the
Securities Act of 1933, as amended, and may not be offered or sold
in the United States absent registration or an applicable exemption
from registration requirements.
Forward Looking Statements
Except for the historical information contained herein, the
matters set forth in this press release are forward-looking
statements within the meaning of the “safe harbor” provisions of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, but are not limited to,
statements regarding the Transactions and the Agreement, including
receipt of required approvals and satisfaction of other customary
closing conditions and excepted timing of closing of the
Transactions, and expectations of future plans, strategies, and
benefits of the Transactions. The words ”anticipate,” "believe,”
”continue,” “could,” “estimate,” “expect,” “intends,” “may,”
“might,” ”plan,” “possible,” “potential,” “predict,” “project,”
“should,” “would” and similar expressions may identify
forward-looking statements, but the absence of these words does not
mean that a statement is not forward-looking. Forward-looking
statements are based on our management’s beliefs, as well as
assumptions made by, and information currently available to, them.
Because such statements are based on expectations as to future
financial and operating results and are not statements of fact,
actual results may differ materially from those projected.
Important factors that could cause actual results to differ
materially from those expressed in the forward-looking statements
include, among others: the ultimate outcome of the transaction,
including obtaining the requisite vote of securityholders; the
Company’s ability to meet expectations regarding the timing and
completion of the transaction; and the risks, uncertainties, and
factors set forth under “Risk Factors” in the Company’s most recent
Annual Report on Form 10-K and its subsequently filed Quarterly
Reports on Form 10-Q. Forward-looking statements speak only as of
the date they are made. The Company assumes no obligation to update
forward-looking statements to reflect actual results, subsequent
events, or circumstances or other changes affecting such statements
except to the extent required by applicable law.
Forward-looking statements speak only as of the date they are
made. Readers are cautioned not to put undue reliance on
forward-looking statements, and, except as required by law, the
Company assumes no obligation and does not intend to update or
revise these forward-looking statements, whether as a result of new
information, future events, or otherwise.
Beneficient (NASDAQ:BENF)
Historical Stock Chart
From Dec 2024 to Jan 2025
Beneficient (NASDAQ:BENF)
Historical Stock Chart
From Jan 2024 to Jan 2025